These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 2811943

  • 1. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
    Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A.
    N Engl J Med; 1989 Nov 16; 321(20):1349-52. PubMed ID: 2811943
    [Abstract] [Full Text] [Related]

  • 2. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A.
    N Engl J Med; 1998 Jan 08; 338(2):73-8. PubMed ID: 9420337
    [Abstract] [Full Text] [Related]

  • 3. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L, Lundell G, Tørring O, Wallin G, Ljunggren JG, Blomgren H, Taube A.
    N Engl J Med; 1992 Jun 25; 326(26):1733-8. PubMed ID: 1489388
    [Abstract] [Full Text] [Related]

  • 4. Graves' ophthalmopathy and 131I therapy.
    Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A.
    Q J Nucl Med; 1999 Dec 25; 43(4):307-12. PubMed ID: 10731781
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M.
    Srp Arh Celok Lek; 2000 Dec 25; 128(5-6):179-83. PubMed ID: 11089418
    [Abstract] [Full Text] [Related]

  • 6. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA, Daykin J, Holder R, Sheppard MC.
    QJM; 1995 Mar 25; 88(3):175-80. PubMed ID: 7767667
    [Abstract] [Full Text] [Related]

  • 7. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF, Mourits MP, Berghout A, Krenning EP, van der Gaag R, Koornneef L, Wiersinga WM.
    N Engl J Med; 1989 Nov 16; 321(20):1353-9. PubMed ID: 2519530
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC, Zanin DE, Zweers EJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370
    [Abstract] [Full Text] [Related]

  • 9. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A.
    Thyroid; 1992 Sep 28; 2(2):171-8. PubMed ID: 1525588
    [Abstract] [Full Text] [Related]

  • 10. Radioiodine therapy and Graves' ophthalmopathy.
    Sisson JC, Schipper MJ, Nelson CC, Freitas JE, Frueh BR.
    J Nucl Med; 2008 Jun 28; 49(6):923-30. PubMed ID: 18483104
    [Abstract] [Full Text] [Related]

  • 11. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J, Kretowski A, Topolska J, Siewko K, Jakubczyk D, Szelachowska M, Mikita A, Kinalska I.
    Horm Metab Res; 2001 Dec 28; 33(12):739-43. PubMed ID: 11753760
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov 28; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 13. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R, Sripathy G.
    Natl Med J India; 2000 Nov 28; 13(5):246-51. PubMed ID: 11190053
    [Abstract] [Full Text] [Related]

  • 14. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R, Séra T, Valkusz Z, Julesz J, Csernay L, Pávics L.
    Orv Hetil; 1999 Jun 06; 140(23):1291-5. PubMed ID: 10412264
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF, Scholz GH.
    Med Klin (Munich); 2004 Feb 15; 99(2):71-6. PubMed ID: 14963657
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A, Malabu UH, El-Desouki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, Al-Maatouq MA, Sulimani RA.
    Saudi Med J; 2007 Feb 15; 28(2):225-30. PubMed ID: 17268701
    [Abstract] [Full Text] [Related]

  • 17. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A, Perrino S, Coronella C, Sansone D, Ruocco G, Tirelli G, Di Martino S, Conte M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2004 Jun 15; 60(6):694-8. PubMed ID: 15163332
    [Abstract] [Full Text] [Related]

  • 18. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S, Rudolph F, Prillwitz A, Groth P, Schümichen C.
    Nuklearmedizin; 1998 Jan 15; 37(1):23-9. PubMed ID: 9467166
    [Abstract] [Full Text] [Related]

  • 19. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R.
    Arch Intern Med; 1990 May 15; 150(5):1098-101. PubMed ID: 1691908
    [Abstract] [Full Text] [Related]

  • 20. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.
    Radiol Med; 2000 Dec 15; 100(6):480-3. PubMed ID: 11307510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.